Marrow is building AI models that leverage a new form of biological data to understand cancer with unprecedented clarity and bring about a new era where the right drug meets the right patient, every time.

The company is founded by Andrew Leber, who previously built and sold a software company and left a PhD in cancer biology at Oxford. He’s joined by advisors across oncology, machine learning, and biotech commercialization.